Regulatory Perspective Based on Survey of Relationship Between Biopharmaceutical Characteristics and Food Effects on Systemic Pharmacokinetics

Documenti analoghi

• A Phase I Trial of the Pharmacokinetic Interaction Between Cannabidiol and Tacrolimus
  di: Gerald C. So, et al.
  Pubblicazione: (2024)
• Dosage Optimization: A Regulatory Perspective for Developing Oncology Drugs
  di: Atiqur Rahman, et al.
  Pubblicazione: (2024)
• Machine Learning‐Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents
  di: Ethan A. Poweleit, et al.
  Pubblicazione: (2024)
• Characteristics of Drugs from Non‐Global Companies for Hematologic Malignancies and Impact on Global Regulatory Approval
  di: Kensuke Matsuda, et al.
  Pubblicazione: (2024)
• Predicting Clinical Pharmacokinetics/Pharmacodynamics and Impact of Organ Impairment on siRNA‐Based Therapeutics Using a Mechanistic Physiologically‐Based Pharmacokinetic‐Pharmacodynamic Model
  di: Annie Lumen, et al.
  Pubblicazione: (2024)